NFKB1 and diffuse large B-cell lymphoma: Kloo et al. found that inhibiting PI3K in activated B cell like diffuse large B cell lymphoma (ABC DLBCL) cells decreased NF-κB target genes, which led to decreased survival of the ABC DLBCL cells (60).